Short Ideas

[gfp927z]

CHM, Any consensus over on the CTIX board concerning the financing? I've been thinking they would do a 15 mil share deal at $3, netting $45 mil range, but that's just a guess. A partnership would be another possibility, though probably less likely.

Cempra (CEMP) and Tetraphase (TTPH) are also good looking stocks in the antibiotic sector. There's been a lot of acquisitions in the sector over the past year or so, including Trius and Optimer gobbled up by Cubist, and Durata by Actavis, and now Cubist by Merck. So antibiotics have become one of the hotter sectors in biotech.